Literature DB >> 1862057

Screening mammography rates and barriers to use: a Los Angeles County survey.

R Bastani1, A C Marcus, A Hollatz-Brown.   

Abstract

The use of screening mammography among women 40 years of age and older in Los Angeles County was assessed through a random digit dial telephone interview. The sample of 802 women represents a large urban population with substantial proportions of blacks, Hispanics, and Asians. The survey obtained information regarding adherence to the ACS/NCI screening mammography guidelines, perceived benefits of early detection and mammography, perceived threat of developing breast cancer, and barriers to utilization. The results showed that 71% of the women had had at least one mammogram, with 49% having received a screening mammogram according to the guidelines for their age. Less than half the respondents knew the screening guidelines for their age, with women ages 40-49 years being less knowledgeable than women greater than or equal to 50 years old (29 vs 58% answering correctly). A logistic regression analysis predicting the likelihood of having obtained a screening mammogram according to the guidelines found the following to be predictive: concern over radiation (negative association), age (negative association), family history, knowledge of guidelines, and cost of a mammogram (negative association). Other demographic factors and beliefs were not significantly related to this dependent variable.

Entities:  

Mesh:

Year:  1991        PMID: 1862057     DOI: 10.1016/0091-7435(91)90034-2

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  18 in total

1.  Multistrategy health education program to increase mammography use among women ages 65 and older.

Authors:  B K Rimer; N Resch; E King; E Ross; C Lerman; A Boyce; H Kessler; P F Engstrom
Journal:  Public Health Rep       Date:  1992 Jul-Aug       Impact factor: 2.792

2.  Screening mammography and constructs from the transtheoretical model: Associations using two definitions of the stages-of-adoption.

Authors:  W Rakowski; B Ehrich; C E Dubé; D N Pearlman; M G Goldstein; K K Peterson; B K Rimer; H Woolverton
Journal:  Ann Behav Med       Date:  1996-06

3.  Differing beliefs about breast cancer among Latinas and Anglo women.

Authors:  F A Hubbell; L R Chavez; S I Mishra; R B Valdez
Journal:  West J Med       Date:  1996-05

4.  Factors associated with women's adherence to mammography screening guidelines.

Authors:  K A Phillips; K Kerlikowske; L C Baker; S W Chang; M L Brown
Journal:  Health Serv Res       Date:  1998-04       Impact factor: 3.402

5.  A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use.

Authors:  M D Schwartz; B K Rimer; M Daly; C Sands; C Lerman
Journal:  Am J Public Health       Date:  1999-06       Impact factor: 9.308

6.  Health Belief Model variables as predictors of screening mammography utilization.

Authors:  R B Hyman; S Baker; R Ephraim; A Moadel; J Philip
Journal:  J Behav Med       Date:  1994-08

7.  Mammography screening of women in their 40s: impact of changes in screening guidelines.

Authors:  Lisa Calvocoressi; Albert Sun; Stanislav V Kasl; Elizabeth B Claus; Beth A Jones
Journal:  Cancer       Date:  2008-02-01       Impact factor: 6.860

8.  Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older.

Authors:  Saleh M M Rahman; Mark B Dignan; Brent J Shelton
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

9.  Breast cancer knowledge and practices among D/deaf women.

Authors:  Barbara A Berman; Angela Jo; William G Cumberland; Heidi Booth; Jon Britt; Carolyn Stern; Philip Zazove; Gary Kaufman; Georgia Robins Sadler; Roshan Bastani
Journal:  Disabil Health J       Date:  2013-06-30       Impact factor: 2.554

10.  Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city.

Authors:  Adenike O Akhigbe; Vivian O Omuemu
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.